Quick Answer
Modular Medical, Inc. reported Research And Development Expense of $14.70 million for the year ending 2025.
- Modular Medical, Inc. showed an increase of +14.1% in Research And Development Expense from 2024 to 2025.
- This data is from Modular Medical, Inc.'s annual report (Form 10-K), filed with the SEC on June 20, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2016: $0.00 | Q2 2017: $0.00 | Q3 2017: $83.4 thousand | Q4 2017: $171.0 thousand | Q2 2018: $135.8 thousand | Q3 2018: $367.6 thousand | Q4 2018: $504.8 thousand | Q2 2019: $703.8 thousand | Q3 2019: $633.2 thousand | Q4 2019: $608.0 thousand | Q2 2020: $970.8 thousand | Q3 2020: $1.09 million | Q4 2020: $1.09 million | Q2 2021: $1.79 million | Q3 2021: $2.11 million | Q4 2021: $1.85 million | Q2 2022: $2.22 million | Q3 2022: $2.39 million | Q4 2022: $2.20 million | Q2 2023: $2.77 million | Q3 2023: $3.16 million | Q4 2023: $3.84 million | Q2 2024: $3.21 million | Q3 2024: $3.70 million | Q4 2024: $3.85 million | Q2 2025: $5.13 million | Q3 2025: $5.59 million | Q4 2025: $5.41 million.
- Historical annual values: Fiscal year 2025: $14.70 million | Fiscal year 2024: $12.88 million | Fiscal year 2023: $9.06 million | Fiscal year 2022: $7.73 million | Fiscal year 2021: $4.08 million | Fiscal year 2020: $3.03 million | Fiscal year 2019: $1.88 million | Fiscal year 2018: $332.6 thousand | Fiscal year 2017: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: